LONDON (Reuters) - GlaxoSmithKline Plc is acquiring Biotene, a leading over-the-counter treatment for dry mouth, for $170 million in a move to bolster its consumer healthcare business. The world's ...

The experts consulted for this story do not necessarily endorse the products ahead unless otherwise noted. Chronic and noticeably bad breath is a condition that affects many of us. We’ve previously ...

NEW YORK GlaxoSmithKline is buying rights to the dry-mouth drug Biotene from California drug maker Laclede, GSK has announced. “The acquisition of Biotene extends our portfolio in therapeutic oral ...

(KFVS)- This has probably happened to you at some point when owning pets: they get really, really bad breath. You've tried dental chews, treats, changing their food, even brushing their teeth, and ...

This report is based on the performance of biotène in the United States. Incorporating data from Statista’s Consumer Insights Brand KPIs survey, the report provides you with key consumer insights and ...

MPR, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient outcomes.

People using oral care products (excluding toothpaste) in the United Kingdom Supermarket brands of oral care products (excluding toothpaste) in the United Kingdom To download this statistic in XLS ...